MENU
RIGL
AS OF
Dec 24 closing price
Price
$44.64
Change
+$0.70 (+1.59%)
Capitalization
810.28M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rigel Pharmaceuticals (RIGL) Ownership - Who owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
810.28M
P/E Ratio
7.21
Total Cash
137.14M
Projected Growth
N/A
Total Debt
60.88M
Revenue
282.08M
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash/Share
7.56
Total Debt/Equity
N/A
Revenue/Share
15.44 USD as % of share price

Fundamentals

RIGL
Capitalization
810M
P/E Ratio
7.21
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
7.56
Total Debt
60.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
15.44%
Revenue
282M
ROE
N/A
Book Value
118M
P/B Ratio
6.89
Cash Flow
N/A
Earnings
6.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18K
Current Ratio
2.28
Current Revenue Per Employee
423548.78
Dividends Per Share - Security
N/A
EBITDA
124M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.16
Revenue To Assets
59.33
Shares Held By Institutions
624M
Shares Outstanding - Current
18.2M
Total Liabilities
125M
Total Volume MTD
N/A
Value
N/A
Gain YTD
165.398
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RIGL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for RIGL
A.I. Advisor
published General Information

General Information

a clinical-stage drug development company that discovers and develops novel, small-molecule drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com